
GRDN Stock Forecast & Price Target
GRDN Analyst Ratings
Bulls say
Guardian Pharmacy Service is in a strong financial position with a solid market share and potential for growth through strategic M&A. With a focus on providing high-quality services to residents of LTCFs and a strong customer experience, the company is well-positioned for continued success. Regulatory changes in the industry also provide potential for further growth and expansion.
Bears say
Guardian Pharmacy Service is poised to experience strong organic growth due to an aging baby boomer population and its three-pronged growth strategy focused on increasing adoption rates, adding new accounts, and expanding into neighboring markets. However, its operations may face challenges with reimbursement and regulatory uncertainty, as well as the potential impact of Medicare's new drug pricing regulations in 2026. Additionally, the company's local autonomy model and strong employee benefits may differentiate it from competitors, but there is opportunity for margin improvement through shared systems and AI implementation. Overall, the company presents both growth potential and challenges, warranting a cautious outlook from a financial analyst.
This aggregate rating is based on analysts' research of Guardian Pharmacy Services Inc and is not a guaranteed prediction by Public.com or investment advice.
GRDN Analyst Forecast & Price Prediction
Start investing in GRDN
Order type
Buy in
Order amount
Est. shares
0 shares